跳至主要内容
临床试验/JPRN-UMIN000001552
JPRN-UMIN000001552已完成未知

Health-related quality of life of postmenopausal women treated with Letrozole as adjuvant therapy for hormone receptor-positive early breast cancer (SBCCSG-15) - Health-related quality of life of postmenopausal women treated with Letrozole as adjuvant therapy for hormone receptor-positive early breast cancer (SBCCSG-15)

PO Saitama Breast Cancer Clinical Study Group (SBCCSG)0 个研究点目标入组 200 人开始时间: 2008年12月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1. patients have been treated with medicine which may have some effect for sex hormone or trastuzumab 2. patients being treated with chemotherapy 3. Serious complications ( e.g malignant hypertension, CHF, hepatic failure, MI within 6 months, PE, arrhythmia treatment needed, infection, hemorrhagic tendency ) 4. active multiple cancer

研究者

发起方
PO Saitama Breast Cancer Clinical Study Group (SBCCSG)

相似试验